Table 2:
Author, Year N (TAVI/SAVR) | Patients Not Randomized, N (%) | Procedure Not Attempted, n (%) | Procedure Attempted but Valve Not Implanted, n (%) | Withdrawal After Implantation Procedure, n (%) |
---|---|---|---|---|
Mack et al, 201918 1,000 (503/497) PARTNER 3 |
520 (34.2) Reasons:
|
TAVI: 7 (1.4) SAVR: 43 (8.7) Reasons: Ineligible TAVI: 1 (0.2) SAVR: 8 (1.6) Consent withdrawn TAVI: 6 (1.2) SAVR: 35 (7.0)a |
TAVI: 1 (0.2)—converted to SAVR SAVR: 1 (0.2)—procedure aborted |
Patient withdrawal or loss to follow-up TAVI: 1 (0.2) SAVR: 16 (3.5) |
Popma et al, 201917 1,468 (734/734) Evolut LRT |
255 (14.7) Reasons:
|
TAVI: 13 (1.8) SAVR: 53 (7.2) Reasons: Ineligible TAVI: 1 (0.1) SAVR: 4 (0.5) Consent withdrawn TAVI: 8 (1.1) SAVR: 33 (4.5) Withdrawn by physician TAVI: 1 (0.1) SAVR: 12 (1.6) Death TAVI: 0 SAVR: 1 (0.1) Lost to follow-up TAVI: 0 SAVR: 2 (0.3) Pending procedure TAVI: 2 (0.3) SAVR: 1 (0.1) |
TAVI: 4 (0.5)—underwent surgery SAVR: 2 (0.3)—underwent TAVI (1), valve not implanted (1) |
Patient withdrawal or loss to follow-up TAVI: 9 (1.2) SAVR: 27 (3.7) |
Abbreviations: SAVR, surgical aortic valve replacement; TAVI, transcatheter aortic valve implantation.
Decided not to undergo surgery or to undergo surgery at a nontrial hospital.
Aortic dimensions outside of the sizing guidelines (n = 60), predicted risk of mortality was outside of the protocol criteria (n = 6), bicuspid aortic valve (n = 138), prohibitive left ventricular outflow tract calcification (n = 18), anatomy unsuited for TAVI access (n = 1), other reasons (n = 2). Patients could have had multiple reasons for disapproval.